- BioNotebook: Up to $2.6bn in post-JP Morgan stock offerings, plus six IPO updates
- Lung data give welcome boost to Boehringer's Gilotrif
- IPO UPDATE: Are investors cooling to new biotech offerings?
- US Capitol Capsule: How to beat China in innovation race? Fine pharma
- Patient centricity in big pharma – A How-to Guide
- Profile: Janssen R&D boss on the next big thing in medicine & 'ice bucket' funding